Skip to content

Interictal 11C-flumazenil PET/mpMRI Detect Epileptogenic Zone of Drug-refractory epilepsy:A Pilot Study

Preoperative localization of interictal 11c-fmz PET imaging in patients with drug refractory epilepsy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071941
Enrollment
Unknown
Registered
2023-05-30
Start date
2023-05-25
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Drug-refractory epilepsy

Interventions

Gold Standard:Postoperative pathological results or stereotactic intracranial electroencephalogram (SEEG) results
Index test:3D-T1WI sequence: gray matter volume (GMV), gray matter concentration (GMC), cortical thickness DTI sequence: fractional anisotropy (FA), mean diffusivity (MD), apparent diffusion coeffici

Sponsors

General Hospital of Northern Theater Command
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Age: age =18 years old; 2) Clear clinical diagnosis: drug-resistant epilepsy failed to achieve sustained seizure free after application of correctly selected and tolerated antiepileptic drugs (monotherapy or combination therapy). 3) No seizures within 2 hours before examination. 4) Good compliance, able to cooperate to complete PET imaging

Exclusion criteria

Exclusion criteria: 1) Patients who did not meet the inclusion criteria; 2) Patients with allergic constitution; 3) Patients with contraindications to MR Or CT examination; 4) Patients with a history of brain surgery; 5) Patients with serious organic diseases of the heart, liver or kidney; 6) Severely obese patients (body weight > 150KG); 7) Pregnant or lactating women or patients with recent plans to have children; 8) Not considered appropriate for participants by the investigator

Design outcomes

Primary

MeasureTime frame
Standardized uptake value ratio(SUVr);

Secondary

MeasureTime frame
Gray matter volume;Gray matter concentration;Fractional anisotropy;Mean diffusivity;Apparent diffusion coefficient;Amplitude of low frequency fluctuation;

Countries

China

Contacts

Public ContactGuoxu Zhang

General Hospital of Northern Theater Command

zhangguoxu502@sina.com+86 133 5245 8228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026